GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » Retained Earnings

Vilacto Bio (Vilacto Bio) Retained Earnings : $-8.47 Mil (As of Jun. 2019)


View and export this data going back to 2013. Start your Free Trial

What is Vilacto Bio Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Vilacto Bio's retained earnings for the quarter that ended in Jun. 2019 was $-8.47 Mil.

Vilacto Bio's quarterly retained earnings declined from Dec. 2018 ($-6.35 Mil) to Mar. 2019 ($-7.86 Mil) and declined from Mar. 2019 ($-7.86 Mil) to Jun. 2019 ($-8.47 Mil).

Vilacto Bio's annual retained earnings declined from Mar. 2017 ($-0.11 Mil) to Mar. 2018 ($-1.00 Mil) and declined from Mar. 2018 ($-1.00 Mil) to Mar. 2019 ($-7.86 Mil).


Vilacto Bio Retained Earnings Historical Data

The historical data trend for Vilacto Bio's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilacto Bio Retained Earnings Chart

Vilacto Bio Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
Retained Earnings
Get a 7-Day Free Trial -0.07 -0.09 -0.11 -1.00 -7.86

Vilacto Bio Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.95 -3.28 -6.35 -7.86 -8.47

Vilacto Bio Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Vilacto Bio  (GREY:VIBI) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Vilacto Bio (Vilacto Bio) Business Description

Traded in Other Exchanges
N/A
Address
Fabriksvej 48, Suite 2607, The Seagram Building, Naestved, DNK, 4700
Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.